Becker R, Gass N, Kußmaul L, Schmid B, Scheuerer S, Schnell D, et al. NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats. Psychopharmacology (Berl). 2019;236:3451-3463 pubmed publisher

Chen B, Li Y, Yu B, Zhang Z, Brommer B, Williams P, et al. Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations. Cell. 2018;174:521-535.e13 pubmed publisher

Stasiuk W, Szopa A, Serefko A, Wyska E, Swiader K, Dudka J, et al. Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice. J Neural Transm (Vienna). 2017;124:387-396 pubmed publisher

Prakash C, Cui D, Potchoiba M, Butler T. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs. Drug Metab Dispos. 2007;35:1350-64 pubmed

Taylor T, Diringer K, Russell T, Venkatakrishnan K, Wilner K, Crownover P, et al. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers. Clin Pharmacokinet. 2006;45:989-1001 pubmed